Véronique Hofman - Concepedia

Author

Véronique Hofman

Also Known As

H. Véronique, Hofman, Véronique, Michael Perrais, Paul Hofman, V Battaglione, V Hofman, V. Hofman, Veronique Hofman, Véronique Hofman, Véronique Battaglione

402

Publications

11K

Citations

H-Index

120

Concepts

All Affiliations

Inserm Université Côte d'Azur Hôpital Pasteur Centre National de la Recherche Scientifique Centre Hospitalier Universitaire de Nice

About

Véronique Hofman is an author at Inserm specializing in medicine, pathology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	66	4.7K
2	Health Sciences	7	8	703
3	Engineering	5	5	262
4	Public Health	2	2	31
5	Natural Sciences	1	1	248

Véronique Hofman

125

Publications

8.8K

Citations

H-Index

Page 1

	Year	Citations
Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies Marius Ilié, Élodie Long-Mira, Coraline Bence, Annals of Oncology Translational MedicineClinical TranslationMedicinePathologyImmune Checkpoint Inhibitor	2015	566
“Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease Marius Ilié, Véronique Hofman, Élodie Long-Mira, PLoS ONE Prognostic BiomarkersCancer DetectionAdvanced Lung DiseaseMedicinePathology	2014	413
miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity Marie-Pierre Puisségur, Nathalie M. Mazure, Thomas Bertero, Cell Death and Differentiation	2010	410
Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker Véronique Hofman, Christelle Bonnetaud, Marius Ilié, Clinical Cancer Research	2010	312
Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non‐small‐cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method Véronique Hofman, Marius Ilié, Élodie Long-Mira, International Journal of Cancer	2010	300
Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance Michaël Cerezo, Abdelali Lehraiki, Antoine Millet, Cancer Cell MedicinePhotocarcinogenesisMelanomaAnti-cancer AgentDermatology	2016	251
Senescent cells develop a PARP-1 and nuclear factor-κB-associated secretome (PNAS) Mickaël Ohanna, Sandy Giuliano, Caroline Bonet, Genes & Development Protein SecretionImmunologyImmune RegulationCancer BiologyCellular Physiology	2011	248
Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny Yann Chéli, Serena Guiliano, Thomas Botton, Oncogene Developmental BiologyCell RegulationCell DivisionHuman MelanomaMedicine	2011	229
Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids Nicolas Alcala, Noémie Leblay, Alice‐Agnes Gabriel, Nature Communications	2019	205
Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications Yuna Blum, Clément Meiller, Lisa Quetel, Nature Communications	2019	197

Page 1